Tuesday, March 21, 2023
Syneos Health® announced a strategic multi-year agreement with Microsoft. The multi-year agreement includes collaboration with Microsoft Research and leverages developments from OpenAI. Through this collaboration, Syneos Health will deliver technology and data solutions with Microsoft that accelerate clinical development and elevate commercial performance for biopharma customers.
Based on AI-enabled platform, Syneos Health will be able to process and analyse data to fast-track timelines, optimise resource allocation and unlock clinical trial efficiencies. These capabilities will allow for superior site selection and reduced enrolment timelines to bring new treatments to patients faster. Syneos Health combines AI expertise with solutions that help make a big difference in patients' lives.